Related Experiment Video
Updated: Nov 13, 2025

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Anna Pia Delli Bovi1, Francesca Marciano1,2, Claudia Mandato3
1Pediatrics Section, Department of Medicine and Surgery, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.
Abstract:
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which may partly explain why it remains still orphan of an adequate therapeutic strategy. Herein we focus on the interplay between oxidative stress (OS) and the other causal pathogenetic factors. Different reactive oxygen species (ROS) generators contribute to NAFLD inflammatory and fibrotic progression, which is quite strictly linked to the lipotoxic liver injury from fatty acids and/or a wide variety of their biologically active metabolites in the context of either a two-hit or a (more recent) multiple parallel hits theory. An antioxidant defense system is usually able to protect hepatic cells from damaging effects caused by ROS, including those produced into the gastrointestinal tract, i.e., by-products generated by usual cellular metabolic processes, normal or dysbiotic microbiota, and/or diet through an enhanced gut-liver axis. Oxidative stress originating from the imbalance between ROS generation and antioxidant defenses is under the influence of individual genetic and epigenetic factors as well. Healthy diet and physical activity have been shown to be effective on NAFLD also with antioxidant mechanisms, but compliance to these lifestyles is very low. Among several considered antioxidants, vitamin E has been particularly studied; however, data are still contradictory. Some studies with natural polyphenols proposed for NAFLD prevention and treatment are encouraging. Probiotics, prebiotics, diet, or fecal microbiota transplantation represent new therapeutic approaches targeting the gut microbiota dysbiosis. In the near future, precision medicine taking into consideration genetic or environmental epigenetic risk factors will likely assist in further selecting the treatment that could work best for a specific patient.
Insights
Non-alcoholic fatty liver disease (NAFLD) involves oxidative stress (OS) and gut microbiota. Current treatments are limited, but antioxidants and gut-targeting therapies show promise for managing this complex liver condition.
Area of Science:
- Hepatology
- Oxidative Stress Research
- Gastroenterology
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition lacking adequate therapeutic strategies.
- Oxidative stress (OS) and gut microbiota dysbiosis are key contributors to NAFLD pathogenesis.
- The gut-liver axis plays a significant role in NAFLD development and progression.
Purpose of the Study:
- To explore the intricate interplay between oxidative stress and other pathogenetic factors in NAFLD.
- To review current and emerging therapeutic approaches for NAFLD.
- To highlight the potential of precision medicine in tailoring NAFLD treatments.
Main Methods:
- Review of existing literature on NAFLD pathogenesis, focusing on oxidative stress and gut microbiota.
- Analysis of the role of reactive oxygen species (ROS) generators and antioxidant defenses.
- Evaluation of therapeutic strategies including antioxidants, dietary interventions, and microbiota modulation.
Main Results:
- Reactive oxygen species (ROS) contribute to NAFLD progression, linked to lipotoxicity and inflammation.
- Antioxidant defenses can be overwhelmed by ROS, influenced by genetic and epigenetic factors.
- While lifestyle changes and vitamin E show mixed results, natural polyphenols, probiotics, and prebiotics are promising.
Conclusions:
- NAFLD management is complex due to multiple interacting factors.
- Targeting gut microbiota dysbiosis and oxidative stress offers potential therapeutic avenues.
- Precision medicine approaches considering individual risk factors are crucial for future NAFLD treatment selection.

